Related by context. Frequent words. (Click for all words.) 70 efficacy endpoints 65 secondary endpoint 65 secondary endpoints 64 composite endpoint 63 primary endpoint 62 Secondary endpoints 62 primary efficacy endpoint 62 primary endpoints 60 efficacy 60 pharmacodynamic 59 CoFactor 58 phase IIb 58 statistical significance 58 myelofibrosis 57 elagolix 57 Phase IIb clinical 57 clinically meaningful 57 SPIRIT III 57 ACR# [002] 57 picoplatin 57 LymphoStat B 57 ACTEMRA 57 vandetanib 57 palliation 57 placebo controlled trials 57 cardiovascular morbidity 56 tolerability 56 achieve statistical significance 56 limiting toxicity 56 Phase III clinical 56 dimebon 56 dose limiting toxicities 56 AZD# 56 sustained virologic response 55 PS# [001] 55 randomized controlled clinical 55 non inferiority 55 eculizumab 55 clinical trial 55 talactoferrin 55 pirfenidone 55 Phase IIa clinical 55 Phase 2b study 55 bosentan 55 liver metastases 55 PXD# 55 Torisel 55 EORTC 55 L MTP PE 55 daclizumab 55 lacosamide 55 ticagrelor 55 Bronchitol 55 methylnaltrexone 54 Zerenex 54 tolerated dose MTD 54 clinical trials 54 randomized clinical trials 54 dosing regimens 54 Phase Ib 54 denufosol 54 Phase 2a trial 54 pharmacokinetic 54 sunitinib 54 tiotropium 54 Phase IIa trial 54 dasatinib 54 biologic therapy 54 Azixa 54 prognostic factors 54 substudy 54 DR Cysteamine 54 BAY #-# 54 TroVax 54 Secondary endpoints included 54 CA4P 54 Phase IIb trial 54 Phase 2b clinical 54 eltrombopag 54 tolerability profile 54 INCB# [002] 53 tumor recurrence 53 pivotal Phase III 53 clinically relevant 53 Empatic 53 FTY# 53 azacitidine 53 bioequivalence 53 Phase III trials 53 adalimumab 53 CYT# 53 PEG Interferon lambda 53 aetiology 53 Phase III 53 SEROQUEL 53 Taxotere ® 53 pharmacokinetic profile 53 cethromycin 53 RCTs 53 Phase IIb 53 histologic